World Cancer Congress 2018 | ECS progastrin | Kuala Lumpur
logo ECS progastrine_noir-rouge.jpg
logo ECS progastrine_noir-rouge.jpg

Meet us on the ECS screening's booth at the upcoming World Cancer Congress

Kuala Lumpur - Malaysia

Capture d’écran 2018-09-24 à 08.08.16.pn

ECS screening

 

E26 > E29

WCC2018

UICC

FROM

1 TO 4

OCT 2018

In association with PROGASTRIN cancer control Association,

ECS progastrin is proud to present the Progastrin's WHITE PAPER 

Progastrin and its link to cancer:

from the discovery of progastrin   to tumor reversion  

by Dominique Joubert, PhD in biology

and Alexandre Prieur, PhD in oncology

click on this icon to download the document

Couv Progastrin White Paper.jpg
 

Secure your future

Contact us

ECS progastrin

Chemin de la Meunière 12

Prilly 1008 Suisse

 

ECS progastrin SA is a subsidiary of

Progastrine Invest SCSp – Cancer Control Funding Fund

11 côte d'Eich, L1450,

Luxembourg City - Grand Duchy of Luxembourg

Progastrine invest

11 côte d'Eich,

L1450 Luxembourg ville

Grand Duché du Luxembourg

ECS progastrin Lab

Chemin de la Meunière 12

Prilly 1008

Suisse

Progastrin Manufacturing

Chemin de la Meunière 12

Prilly 1008

Suisse

Progastrine et cancers

11 côte d'Eich,

L1450 Luxembourg ville

Grand Duché du Luxembourg

Eurobiodev

2040 avenue du Père Soulas

34000 Montpellier

France

Progastrine Invest SCSp and its subsidiaries

  • focus on innovation in cancer screening, diagnosis and treatment,

  • hold the rights to the first circulating progastrin assay, identified as a new marker associated with cancer. This dosage helps to screen for cancer even at early stages and to monitor therapies,

  • are the holders of the rights to the cancer therapy project with an anti-progastrin antibody.

 

For ethical reasons and out of respect for practitioners, health institutions, populations and regulations in force in all countries where they operate, Progastrine Invest SCSp and its subsidiaries pay extreme attention to the information they publicly provide.

 

The management of Progastrine Invest SCSp, its subsidiaries and their scientific committee would like to remind you that only information published on the official communication media of the group's companies can be considered as confirmed and authorised.

© 2018 ECS progastrin